Serotonergic antidepressants are associated with increased bleeding events within 30-days after total shoulder arthroplasty: a propensity-matched analysis of 54,291 patients - Summary - MDSpire
Advertisement
Serotonergic antidepressants are associated with increased bleeding events within 30-days after total shoulder arthroplasty: a propensity-matched analysis of 54,291 patients
To determine the association between perioperative serotonergic antidepressant medications and immediate- and short-term outcomes, including bleeding events and complications, following total shoulder arthroplasty (TSA).
Key Findings:
Patients on serotonergic antidepressants had higher rates of post-operative bleeding events, with specific percentages to be included.
Significant differences in emergency department utilization and hospital readmissions were noted between cohorts, with quantifiable data to be added.
The propensity-matched analysis revealed increased odds of transfusions and hematomas in the SSRI/SNRI group.
Interpretation:
The findings suggest that the use of serotonergic antidepressants during the perioperative period may increase the risk of bleeding complications following TSA, highlighting the need for careful consideration in prescribing these medications.
Limitations:
The study did not assess medication dosage, adherence, or chronicity of antidepressant use, which may influence outcomes.
Data was limited to a single database, which may affect generalizability and introduce potential biases.
Conclusion:
Serotonergic antidepressants are associated with elevated bleeding incidents in the 30 days following TSA, indicating a need for careful consideration of their use in the perioperative setting.
Investigators find that short sleep, insomnia, and night shift work are associated with increased risk of knee and hip osteoarthritis and joint replacement.
Researchers examined how variation in time to hip fracture surgery relates to mortality, complications, length of stay, and functional recovery in older adults.
